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Cerebral Embolism Following
Transcatheter Aortic Valve Implantation
Comparison of Transfemoral and Transapical Approaches
Josep Rodés-Cabau, MD,* Eric Dumont, MD,* Robert H. Boone, MD,† Eric Larose, MD,*
Rodrigo Bagur, MD,* Ronen Gurvitch, MBBS,† Fernand Bédard, MD,‡ Daniel Doyle, MD,*
Robert De Larochellière, MD,* Cleonie Jayasuria, MD,† Jacques Villeneuve, MD,* Alier Marrero, MD,§
Mélanie Côté, MSC,* Philippe Pibarot, PHD,* John G. Webb, MD†
Quebec City and Montreal, Quebec, and Vancouver, British Columbia, Canada
Objectives The objective of this study was to compare the incidence of cerebral embolism (CE) as evaluated by diffusion-
weighted magnetic resonance imaging (DW-MRI) following transapical (TA) transcatheter aortic valve implanta-
tion (TAVI) versus transfemoral (TF) TAVI.
Background The TA-TAVI approach avoids both the manipulation of large catheters in the aortic arch/ascending aorta and
the retrograde crossing of the aortic valve, and this avoidance might lead to a lower rate of CE.
Methods This was a prospective multicenter study including 60 patients who underwent cerebral DW-MRI the day before
and within the 6 days following TAVI (TF approach: 29 patients; TA approach: 31 patients). Neurologic and cogni-
tive function assessments were performed at DW-MRI time points.
Results The TAVI procedure was performed with the Edwards valve and was successful in all cases but one (98%). A to-
tal of 41 patients (68%) had 251 new cerebral ischemic lesions at the DW-MRI performed 4  1 days after the
procedure, 19 patients in the TF group (66%) and 22 patients in the TA group (71%; p  0.78). Most patients
(76%) with new ischemic lesions had multiple lesions (median number of lesions per patient: 3, range 1 to 31).
There were no differences in lesion number and size between the TF and TA groups. No baseline or procedural
factors were found to be predictors of new ischemic lesions. The occurrence of CE was not associated with a
measurable impairment in cognitive function, but 2 patients (3.3%) had a clinically apparent stroke within the
24 h following the procedure (1 patient in each group).
Conclusions TAVI is associated with a high rate of silent cerebral ischemic lesions as evaluated by DW-MRI, with no differ-
ences between the TF and TA approaches. These results provide important novel insight into the mechanisms of
CE associated with TAVI and support the need for further research to both reduce the incidence of CE during
these procedures and better determine their clinical relevance. (J Am Coll Cardiol 2011;57:18–28) © 2011 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.07.036s
s
c
c
a
n
f
d
c
a
a
e
wranscatheter aortic valve implantation (TAVI) has become
n alternative treatment for those patients with symptomatic
rom the *Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec,
anada; †St. Paul’s Hospital, University of British Columbia, Vancouver, British
olumbia, Canada; ‡Department of Neuroradiology, Enfant-Jesus Hospital, Laval
niversity, Quebec City, Quebec, Canada; and the §Montreal Neurological Institute,
cGill University, Montreal, Quebec, Canada. The study was supported by a grant of
he Fondation de l’Institut Universitaire de Cardiologie et de Pneumologie de Quebec and
y a grant (MOP 57745) of the Canadian Institutes of Health Research, Ottawa, Ontario,
anada. Dr. Pibarot holds the Canada Research Chair in Valvular Heart Disease,
anadian Institutes of Health Research, and has received an honorarium and research
rant from Edwards Lifesciences. Drs. Rodés-Cabau, Dumont, Doyle, and Webb are
onsultants for Edwards Lifesciences Inc. Dr. Webb is a consultant for Embrella Inc. All
ther authors have reported that they have no relationships to disclose.p
Manuscript received April 16, 2010; revised manuscript received July 6, 2010,
ccepted July 27, 2010.evere aortic stenosis considered at very high or prohibitive
urgical risk (1). Transfemoral (TF) TAVI is the most
ommonly used approach, and it involves advancing a large
atheter (18- to 24-F) containing the valve through the
ortic arch and retrogradely crossing a severely diseased
ative aortic valve, both well-known potential risk factors
or cerebral embolism (2–5). The risk of cerebral embolism
uring TF-TAVI might be even higher if we take into
onsideration that the population undergoing TAVI now-
days consists of very old patients with a high prevalence of
therosclerotic disease (6,7). Kahlert et al. (8) and Ghanem
t al. (9) have recently shown that TF-TAVI was associated
ith 70% incidence of new cerebral lesions following the
rocedure as evaluated by diffusion-weighted magnetic res-
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December 28, 2010/January 4, 2011:18–28 Cerebral Embolism in TAVInance imaging (DW-MRI). Transapical (TA) TAVI has
ecome an alternative to the TF approach in patients with
onappropriate (i.e., too small, diseased, and/or severely
alcified) iliofemoral arteries (1). The TA approach consists
f directly puncturing the ventricular apex through a small
eft lateral thoracotomy and then advancing the new valve
hrough a catheter inserted through the ventricular apex and
ocated at the mid portion of the left ventricular cavity. It
as been hypothesized that by avoiding both the manipu-
ation of large catheters in the ascending aorta/aortic arch
nd the retrograde crossing of the native aortic valve,
A-TAVI might be associated with a lower rate of cerebral
mbolism. Also, comparing the incidence of cerebral isch-
mia of TA and TF approaches might provide important
ew insights regarding the mechanisms of cerebral embo-
ism associated with TAVI procedures. However, no data
xist on the incidence of cerebral embolism associated with
A-TAVI as evaluated by DW-MRI. The objectives of this
rospective multicenter study were to: 1) compare TA-TAVI
ersus TF-TAVI with respect to the incidence of cerebral
mbolism as evaluated by DW-MRI; and 2) determine the
redictive factors associated with cerebral embolism during the
AVI procedures.
ethods
atients. Patients who underwent TAVI under the Cana-
ian compassionate clinical use program at the Quebec
eart & Lung Institute, Quebec City, Quebec, Canada
January 2008 to February 2010) and St. Paul’s Hospital,
ancouver, British Columbia, Canada (August 2008 to
ecember 2009) were screened for inclusion in the study.
atients with the diagnosis of symptomatic severe aortic
tenosis considered nonoperable or very high surgical risk
andidates were evaluated by a multidisciplinary team com-
osed of interventional cardiologists and cardiac surgeons to
etermine TAVI eligibility. Depending on the size, disease,
nd degree of calcification of iliofemoral arteries as evalu-
ted by aorto-iliofemoral angiography and/or computed
omography (CT), the patients were selected for the TF or
A approach (10). Patients were excluded if they had any
ontraindication to undergo an MRI study or if they were
nable to have an MRI performed within 24 h prior to
AVI. The protocol was approved by the local ethics
ommittee of each center, and all patients provided written
nformed consent to participate in the study.
ransesophageal echocardiography (TEE) and CT. All
atients underwent TEE before and/or during the TAVI
rocedure, and the presence of aortic plaques4 mm in the
scending aorta/aortic arch was recorded. In patients who
nderwent thoracic CT without contrast injection before
he procedure, the CT images of the aortic valve were
nalyzed offline in the cardiac CT core lab of the Quebec
eart & Lung Institute by experienced technicians blinded
o clinical data and supervised by a cardiologist (E.L.).
riefly, a prospective echocardiogram (ECG)-gated scan arotocol was performed during a
ingle breath hold at end-diastole
70% to 80% RR interval) to cover
he entire cardiac silhouette in the
xial plane (64  0.6 mm colli-
ation, reconstruction increment
.5 mm, rotation time 0.33 s) by
oncontrast multidetector CT
Somatom Definition, Siemens
G, Erlangen, Germany). Three-
imensional multiplanar recon-
truction was performed to exam-
ne the aortic valve in-plane
2-mm slice thickness, 2 to 5 slices
er valve for full coverage) and
recisely measure leaflet calcifica-
ions defined as pixels 130
ounsfield units (TeraRecon, San
ateo, California). Aortic valve
eaflet calcium volumes (mm3)
ere determined using the modified Simpson technique
11,12).
AVI procedures. The TAVI procedures have been ex-
ensively detailed in previous studies (10). All procedures
ere performed with the Edwards valve (Edwards SAPIEN
r SAPIEN XT, Edwards Lifesciences Inc., Irvine, Cali-
ornia), which consists of a trileaflet pericardial bovine valve
ounted in a stainless steel (Edwards SAPIEN) or cobalt-
hromium (SAPIEN XT) stent that is deployed by a balloon
xpandable mechanism. The valve was available in 23- and
6-mm sizes. Both TF and TA procedures were performed
nder general anesthesia, with similar anesthesia-ventilation
echniques throughout the entire study period, without
ardiopulmonary bypass. Balloon aortic valvuloplasty was
ystematically performed before valve implantation. In the
F approach, the native aortic valve was crossed with a
tandard straight soft-tip guidewire that was subsequently
xchanged for a stiff guidewire. The balloon-mounted valve
as advanced through a 22-F (23-mm valve) or 24-F
26-mm valve) sheath with the Retroflex delivery catheter
Edwards Lifesciences). After the native aortic valve was
rossed, the new valve was positioned using fluoroscopic,
ngiographic, and TEE guidance and subsequently ex-
anded under rapid pacing (180 to 220 beats/min). The
umber of rapid pacing runs per procedure was recorded.
he TA approach consisted of a direct puncturing of the
entricular apex through a small left lateral thoracotomy and
hen advancing a 26-F sheath through the ventricular apex
p to the mid ventricular cavity. The aortic valve was crossed
ith a soft J tip guidewire that was subsequently exchanged
or a stiff J tip guidewire, which was advanced to the
escending aorta. Following valvuloplasty, the Edwards
alve was advanced antegradely through the 26-F catheter
p to the native aortic valve, and then valve positioning and
eployment followed similar steps as the retrograde TF
Abbreviations
and Acronyms
CT  computed
tomography
DW  diffusion weighted
MMSE  Mini Mental
State Examination
MRI  magnetic resonance
imaging
NIHSS  National
Institutes of Health Stroke
Scale
TA  transapical
TAVI  transcatheter aortic
valve implantation
TEE  transesophageal
echocardiography
TF  transfemoralpproach. In all TA cases, catheter retrieval and ventricular
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Cerebral Embolism in TAVI December 28, 2010/January 4, 2011:18–28pical repair was performed under rapid pacing (13). Anti-
oagulation during the procedure was obtained with intra-
enous heparin, and the dose was adjusted to obtain an
ctivated clotting time250 s. Patients received aspirin and
lopidogrel after the procedure. Procedural success was
efined as the implantation of a functioning valve within the
ortic annulus, without intraprocedural mortality.
erebral DW-MRI procedures. Cerebral DW-MRI ex-
ms were performed within the 24 h before TAVI and
ithin 6 days following the procedure. The DW-MRI was
erformed with a 1.5-T MR unit and a circular polarized
ead coil (Philips Achieva, Best, the Netherlands; General
lectric, Fairfield, Connecticut). The imaging protocol
ncluded isotropic DW (3 orthogonal directions and subse-
uent averaging) and direction-dependent DW (section-
election direction) single-shot echo-planar sequences (rep-
tition time [ms]/echo time [ms] 6,000/100; matrix 128 
28, interpolated to 256  256; section thickness 5 mm;
nd b values 0, 500, and 1,000 s/mm2). Isotropic DW
vercame signal changes in DW caused by anisotropic
iffusion characteristics in white matter fibrous structures.
oreover, apparent diffusion coefficient maps were calcu-
ated to exclude false-positive reading results in the DW
equences caused by a T2 shine-through effect. T2-
eighted turbo spin-echo MRI (2,500/85; matrix 260 
12; flip angle 180°; and section thickness 5 mm) and
1-weighted spin-echo MRI (440/12; matrix 169  256;
ip angle 70°; and section thickness 5 mm) were also
erformed. All DW-MRI exams were analyzed offline by a
euroradiologist blinded to the clinical data. The presence,
umber, size, and location (right vs. left hemisphere; ante-
ior or posterior vascular territory) of all new focal diffusion
bnormalities were recorded.
eurologic and cognitive function assessment. The neu-
ologic assessment was obtained with the National Institutes
f Health Stroke Scale (NIHSS) questionnaire, and the
lobal cognitive function was assessed with the Mini Mental
tate Examination (MMSE). Patients were asked to com-
lete the 2 questionnaires at the same time points as the
erebral MRI exams. The NIHSS is a 15-item scale test
ssessing level of consciousness, gaze, vision, facial palsy,
xtremity weakness, limb ataxia, sensory loss, language, and
ysarthria (14). The MMSE is a 30-point test for evaluation
f cognitive impairment briefly sampling orientation, regis-
ration, attention, calculation, recall, and language (15).
tatistical analyses. Results are expressed as mean  SD
or continuous variables and percentage for categoric pa-
ameters. When a variable was not normally distributed, the
esult was expressed as median (range or interquartile
ange). Comparisons between 2 groups were performed
sing the Student t test or Wilcoxon test for continuous
ariables and the chi-square test for categoric data. Com-
arisons between 2 groups were made using analysis of
ariance (ANOVA) for normally distributed continuous
ata, Kruskal-Wallis for non–normally distributed contin-
ous data, and chi-square test for categoric data. Differences cere considered statistically significant at p  0.05. The
ata were analyzed with SAS statistical software, version
.1.3 (SAS Institute Inc., Cary, North Carolina).
esults
total of 81 patients underwent a cerebral DW-MRI exam
ithin the 24 h before TAVI. Of these, 60 patients had a
econd MRI exam at 4  1 days following the procedure
nd constituted the study population. The reasons for not
erforming the post-procedural MRI in 21 patients were
he following: patient death (n 5), patient refusal (n 6),
emporary or permanent post-procedural pacemaker im-
lantation (n  6), hemodynamic or respiratory instability
n  3), and abortion of the procedure owing to large aortic
nnulus as measured by TEE (n  1). None of the patients
ho did not undergo a second MRI had a clinically
pparent stroke. The clinical, ECG, and CT data of the
tudy population are shown in Table 1. Pre-procedural CT
mages of the native aortic valve were available in 38 of the
0 patients. On the basis of iliofemoral anatomy, 29 patients
48%) were selected for the TF approach and 31 (52%) for
he TA approach. The TA candidates more frequently had
history of coronary artery disease, had a smaller aortic
nnulus size, exhibited a lower amount of calcium in the
ative aortic valve as evaluated by CT, and received more
requently the 23-mm Edwards valve. The procedure was
uccessful in all but one patient (98.4%), in whom the
mpossibility of stabilizing the balloon during balloon
alvuloplasty owing to severe septal hypertrophy protrud-
ng in the left ventricular outflow tract prevented valve
mplantation.
erebral MRI data. Pre-procedural MRI showed the
bsence of acute ischemic lesions in all patients and the
resence of old ischemic lesions in 32 patients (53%), most
f them (84%) 1 cm. Post-procedural DW-MRI data for
he entire study population and for the TF and TA groups
re presented in Table 2. The post-procedural MRI exam
as performed 4  1 days following the TAVI procedure.
total of 251 new ischemic lesions were detected in 41
atients (68%), with a median number of 3 lesions per
atient (range 1 to 36) (Figs. 1 and 2). Most patients (76%)
ith new lesions had multiple lesions that were distributed
n the 2 cerebral hemispheres (73%) and cerebral vascular
erritories (anterior and posterior; 66%). Most lesions (91%)
ere 1 cm in size, and no patient had a lesion 5 cm.
here were no differences between the TF and TA groups
egarding the percent of patients with new ischemic lesions
TF 66%, TA 71%; p  0.78), the median number of
esions per patient (TF 3, 25th to 75th interquartile range:
to 7; TA 4, 25th to 75th interquartile range: 2 to 9; p 
.38), or lesion size (1 cm 92% and 91% in TF and TA
roups, respectively; p  1.0).
The clinical, echocardiographic, CT, and procedural
haracteristics of the patients with new ischemic lesions
ompared with those without new lesions following TAVI are
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December 28, 2010/January 4, 2011:18–28 Cerebral Embolism in TAVIresented in Table 3. Patients with new lesions tended to
ore frequently be male, have a history of coronary artery
isease, and to exhibit a higher transvalvular aortic gradient
t baseline. There were no differences between patients
ith and without new lesions regarding the prevalence of
ortic plaques 4 mm as evaluated by TEE (24% vs.
7%; p  0.36), and the volume of calcium in the native
linical and Procedural Characteristics of the Study PopulationTable 1 Clinical and Procedural Characteristics of the Study Po
Variables
All Patients
(n  60)
Clinical characteristics
Age (yrs) 83 7
Male sex 30 (50)
Diabetes 15 (25)
Dyslipidemia 44 (73)
Hypertension 45 (75)
Current smokers 1 (2)
Chronic atrial fibrillation/flutter 14 (23)
Coronary artery disease 44 (73)
Prior stroke 9 (15)
Peripheral vascular disease 19 (32)
Carotid stenosis 50% 6 (10)
COPD 14 (23)
eGFR 60 ml/min 53 (88)
STS-PROM score (%) 7.7 4.6
Logistic EuroSCORE 18.9 12.8
Echocardiographic variables
Mean aortic gradient (mm Hg) 43 17
Aortic valve area (cm2) 0.63 0.18
LVEF (%) 55 13
LVEF 40% 10 (17)
Aortic annulus diameter (TEE, mm) 22 2
Aortic plaques 4 mm (TEE) 17 (28)
Computed tomography
Aortic valve leaflet calcium volume (mm3) 2,020 (1,350–4,1
Procedural variables
Valve diameter (mm)
23 28 (47)
26 30 (50)
Catheter size (F)
22 10 (17)
24 17 (28)
26 31 (52)
Ratio aortic annulus/valve diameter 0.84 0.17
Rapid pacing runs 5 2
Procedure duration (min) 83 (70–140)
Successful procedure 59 (98)
Procedural complications
Valve embolization 0
Valve malposition 1 (2)
Need for second valve 2 (3)
Severe hypotension needing hemodynamic support 2 (3)
Major access site complications 5 (8)
Life-threatening arrhythmias 2 (3)
alues are expressed as mean  SD, n (%), or median (interquartile range) for skewed variables.
COPD  chronic obstructive pulmonary disease; eGFR  estimated glomerular filtration rate;
ortality; TEE  transesophageal echocardiography.ortic valve (2,340 mm3, range 1,300 to 4,140 mm3 vs. e,830 mm3, range 1,460 to 3,430 mm3; p  0.88).
inally, there were no differences in the procedural
haracteristics of the patients with new lesions compared
ith those without new lesions. The clinical, ECG, CT,
nd procedural characteristics of the study population
rouped according to the presence of none, one, or
ultiple new lesions in the post-procedural DW-MRI
tion
Transfemoral
(n  29)
Transapical
(n  31) p Value
84 7 81 7 0.17
16 (55) 14 (45) 0.61
9 (31) 6 (19) 0.38
17 (59) 27 (87) 0.02
19 (66) 26 (84) 0.14
0 1 (3) 1.00
7 (24) 7 (23) 1.00
17 (59) 27 (87) 0.02
4 (14) 5 (16) 1.00
5 (17) 14 (45) 0.03
2 (7) 4 (13) 0.67
6 (21) 8 (26) 0.77
25 (86) 28 (90) 0.70
8.1 5.5 7.3 3.6 0.55
17.6 11.3 20.1 14.1 0.46
42 15 44 19 0.76
0.67 0.18 0.61 0.17 0.22
52 16 57 11 0.15
7 (24) 3 (10) 0.17
23 2 21 2 0.0001
8 (28) 9 (29) 0.57
2,870 (1,890–5,300) 1,650 (1,300–2,570) 0.04
10 (34) 18 (58) 0.12
17 (59) 13 (42)
10 (34) —
17 (59) —
— 31 (100)
0.84 0.25 0.85 0.04 0.91
4 2 6 2 0.0001
120 (96–180) 72 (65–81) 0.07
28 (97) 31 (100) 0.48
0 0 —
0 1 (3) 1.00
0 2 (6) 0.49
0 2 (6) 0.49
3 (10) 2 (6) 1.00
1 (3) 1 (3) 1.00
left ventricular ejection fraction; STS-PROM  Society of Thoracic Surgeons Predicted Risk Ofpula
40)xam are shown in Table 4. There were no differences
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Cerebral Embolism in TAVI December 28, 2010/January 4, 2011:18–28etween patients with none, one, or multiple new lesions
ollowing TAVI, except for a higher rate of single lesions
n patients with peripheral vascular disease.
eurologic and cognitive function assessment. Post-
rocedural neurologic evaluation with the NIHSS score
howed no differences compared with baseline examinations
median 0, range 0 to 8 for both time periods; p  1.0).
atients with new cerebral ischemic lesions exhibited similar
edian post-procedural NIHSS values as those with no new
esions (0, range 0 to 8 vs. 0, range 0 to 3, respectively; p 
.0). However, clinically apparent neurologic complications
ccurred in 2 patients who presented with a stroke within
4 h following the TAVI procedure. One patient who
nderwent TF-TAVI presented immediately after the pro-
edure with diplopia that persisted up to hospital discharge,
nd another patient who underwent TA-TAVI presented
ith a right-sided stroke. The DW-MRI exams showed
ultiple new cerebral ischemic lesions disseminated in the 2
erebral hemispheres and vascular territories in both pa-
ients (7 and 11 new lesions in the TF and TA patients,
espectively).
The post-procedural cognitive assessment with the
MSE test exhibited similar values to the one performed at
aseline (median 28, range 16 to 30 vs. 28, range 17 to 30;
 0.14). Also, there were no differences in the post-
rocedural MMSE score of the patients with new MRI
esions compared with those without new lesions (28, range
6 to 30 vs. 28, range 18 to 30; p  0.90).
iscussion
AVI was associated with a high rate (68%) of new cerebral
esions as evaluated by DW-MRI. The new cerebral lesions
DW-MRI Findings Following TAVITable 2 DW-MRI Findings Following TAVI
Variables
All
(n
Patients with new lesions 4
Total number of lesions
Lesions per patient 3
Patients with single lesion 1
Patients with multiple lesions 3
Lesion location, patients
Right hemisphere
Left hemisphere
Bilateral lesions 3
Anterior circulation territory
Posterior circulation territory
Anterior and posterior circulation territories 2
Lesion size, cm
1 22
1–5 2
5
Time of post-procedural DW-MRI, days 4
Values are expressed as n (%) or median (interquartile range) for skew
DW-MRI  diffusion-weighted magnetic resonance imaging; TAVI ere multiple and distributed in the 2 cerebral hemispheres nnd vascular territories in most patients, strongly suggesting
n embolic origin. Although the use of large catheters in the
ortic arch/ascending aorta and the retrograde crossing of
he native aortic valve were avoided, the TA approach was
ot associated with a reduction of post-procedural new
erebral lesions compared with the TF approach. No inde-
endent predictors of new lesions were identified among the
linical, echocardiographic, CT, and procedural variables,
nd this included the presence of aortic plaques4 mm and
he amount of calcium in the native aortic valve. Finally, the
ast majority of new cerebral lesions were small and not
ssociated with any measurable impairment in neurologic or
ognitive function. However, 2 patients (3.3%, 1 patient in
ach group) presented with a clinically apparent stroke within
4 h following the procedure.
ncidence of cerebral embolism: the TF and TA
pproaches. Omran et al. (5) showed that patients with
evere valvular aortic stenosis who underwent retrograde
atheterization of the aortic valve had a high risk of cerebral
mbolism, with an incidence as high as 22% as evaluated by
W-MRI in those patients who underwent retrograde
rossing of the aortic valve. Kahlert et al. (8) found an
ncidence of new ischemic lesions following TF-TAVI as
igh as 84% at a median time of 3 days following the
rocedure in 32 patients. A balloon expandable valve
Edwards) was used in most patients in that study.
hanem et al. (9) evaluated the incidence of cerebral
mbolism by DW-MRI in 22 patients who underwent
F-TAVI with a self-expandable valve (CoreValve re-
alving system, Medtronic, Minneapolis, Minnesota). The
ncidence of new cerebral lesions was as high as 73%, with
0% of the patients also exhibiting clinically apparent
ts
)
Transfemoral
(n  29)
Transapical
(n  31) p Value
19 (66) 22 (71) 0.78
83 168
3 (1–7) 4 (2–9) 0.38
5 (26) 5 (23) 1.00
14 (74) 17 (77)
4 (21) 3 (14) 0.68
1 (5) 3 (14)
14 (74) 16 (73)
5 (26) 4 (18) 0.58
3 (16) 2 (9)
11 (58) 16 (73)
) 76 (92) 153 (91) 1.00
7 (8) 15 (9) 1.00
0 0 —
4 (2–6) 5 (3–6) 0.37
iables.
atheter aortic valve implantation.Patien
 60
1 (68)
251
(2–8)
0 (24)
1 (76)
7 (17)
4 (10)
0 (73)
9 (22)
5 (12)
7 (66)
9 (91
2 (9)
0
(2–6)eurologic impairment. Consistent with these results, we
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December 28, 2010/January 4, 2011:18–28 Cerebral Embolism in TAVIound an incidence of 66% of new ischemic lesions follow-
ng TF-TAVI with the Edwards valve. In all of these
tudies, including ours, the new lesions were multiple and
isseminated in the 2 cerebral hemispheres and vascular
erritories, a pattern that strongly suggests an embolic
rigin.
It has been suggested that TAVI by the TA approach
ight be associated with a lower rate of cerebral embolic
Figure 1 DW-MRI Images Following TA-TAVI
Diffusion-weighted magnetic resonance imaging (DW-MRI) images following
transapical transcatheter aortic valve implantation (TA-TAVI) in an 83-year-old
patient showing multiple acute ischemic lesions in the left and right cerebellum
(A, white arrows) and left frontal territory (B and C, white arrows).vents by avoiding the use of large catheters across the aorta pnd the retrograde crossing of the native aortic valve. In this
egard, Himbert et al. (16) and Bleiziffer et al. (17) reported
lower incidence of clinically apparent stroke in patients
ndergoing TA-TAVI compared with those who had
F-TAVI, but these findings have not been confirmed by
ther larger studies including the 2 (TF and TA) ap-
roaches (18–20). The present study is the first to deter-
ine the incidence of cerebral ischemic defects as evaluated
y DW-MRI following TA-TAVI and has shown that the
ate of new ischemic lesions in the TA approach (71%) is
imilar to the rate in the TF approach (66%). Also similar to
he TF approach, new ischemic lesions following TA-
AVI were usually multiple (median number per patient 4,
anging from 1 to 31) and dispersed in the 2 cerebral
emispheres and vascular territories. The similarity in lesion
ate and location between the 2 TAVI approaches suggests
hat the mechanisms responsible for cerebral embolism are
ot solely related to catheter manipulation in the aorta or
etrograde passage through the aortic valve.
echanisms of cerebral embolism associated with TAVI.
he use of diagnostic catheters in the ascending aorta
uring left heart catheterization or coronary interventions
as been associated with a very high rate of cerebral
icroemboli as determined by multifrequency transcranial
oppler (4,21–25). Most (90%) cerebral microemboli
ccurring during left heart catheterization are gaseous and
re usually detected during contrast injection or catheter
ushing; only a minority of these microemboli are solid,
ost likely secondary to mechanical fragmentation of ath-
rosclerotic plaques or clots from the tip of the catheter
2–4). However, despite the very high incidence of micro-
mbolic signals during these procedures, the incidence of
W-MRI lesions has ranged between 10% and 35%
4,26–28), much lower than the rate observed in TAVI.
he TAVI procedure involves the use of both small diag-
ostic catheters for contrast injection throughout the pro-
edure and the use of very large semirigid catheters contain-
ng the crimped stent valve. The advancement of a large
atheter across the aortic arch and ascending aorta in
F-TAVI might have been associated with a significant
umber of solid microemboli (2–4). However, the lack of
ssociation between the occurrence of new ischemic lesions
nd the atherosclerotic risk factors and aortic atheroma
urden in our study, and the similar rate of embolic events
n the TF and TA groups, suggest that this is probably not
he main mechanism of cerebral ischemic lesions during
AVI procedures. On the other hand, the use of very large
atheters in both the TF and TA approaches favors a
ignificant increase in the frequency and severity of air
mbolism. Various studies have shown that gaseous embo-
ism during intra-arterial cardiac or cerebral procedures may
e associated with brain damage and neuropsychologic
eficits (29–32). Air embolism could be of special impor-
ance in TA-TAVI, in which a 26-F catheter is inserted and
ept in the left ventricular cavity throughout the entire
rocedure, with many exchanges through the catheter in-
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rosthesis. In fact, the TEE images usually show several
howers of bubbles during the procedure, especially during
he advancement of the valvuloplasty balloon and transcath-
ter valve. A careful flushing of the catheters before inser-
ion, checking for the presence of air bubbles within the
atheter before balloon/valve insertion, and ensuring ade-
uate patient ventilation with oxygen concentration at 100%
uring insertion and retrieval of the balloon/valve through
he catheter might help to reduce the incidence of cerebral
mbolism during these procedures. Finally, catheter re-
rieval in the TA approach leads to a short direct commu-
ication between the left ventricular cavity and the external
ir space, which might also play a role in the occurrence of
erebral air embolism in these cases.
It has been shown that crossing a stenosed aortic valve
uring retrograde cardiac catheterization was associated
ith up to 22% of silent cerebral embolisms (4), most likely
elated to the dislodgement of calcific valve particles of the
Figure 2 DW-MRI Images Following TF-TAVI
Diffusion-weighted magnetic resonance imaging (DW-MRI) images following transfe
ing multiple acute ischemic lesions in the right cerebellum (A, white arrow), right
arrows), and left and right frontal superior territories (D, white arrows).tenosed valve (33). The TF-TAVI involves crossing the fortic valve with a large catheter and the stent containing
he valve and could contribute to the occurrence of acute
erebral lesions. However, the absence of differences in the
ate of cerebral embolism between TF and TA approaches
uggests that this might not be the main mechanism of
erebral embolism in TF cases. On the other hand, TAVI
nvolves at least 2 episodes of maximum stretching of the
ortic valve leaflets (i.e., balloon valvuloplasty and valve
mplantation). It seems plausible that creating such major
echanical stress on a diseased aortic valve would be
ssociated with the dislodgement of a significant amount of
alve particles that could lead to cerebral embolism. Again,
he fact that the TF and TA approaches had nearly identical
erebral embolism rates suggests that this might be one of
he main mechanisms of cerebral embolism during TAVI
rocedures. However, we did not find any correlation
etween the severity of valve leaflet calcification and the
ccurrence of new cerebral ischemic lesions following
AVI. This lack of association might be due in part to the
transcatheter aortic valve implantation (TF-TAVI) in an 86-year-old patient show-
al territory (B, white arrow), left frontal and right parietal territories (C, blackmoral
occipitact that the quantification of total calcium volume by CT
d
d
c
t
e
i
a
e
h
c
T
e
p
t
n
o
c
l
b
n
ange) f
25JACC Vol. 57, No. 1, 2011 Rodés-Cabau et al.
December 28, 2010/January 4, 2011:18–28 Cerebral Embolism in TAVIoes not necessarily capture the information about the
istribution, location (i.e., calcium nodules located intrinsi-
ally within the valve leaflet or extrinsically at the surface of
he leaflet), and propensity of valvular calcification to
mbolize. Also, the fact that the CT data were not available
n all patients (68%) may have limited the ability to detect
n association between CT calcification scoring and cerebral
mbolism.
It is well known that the occurrence of episodes of severe
ypotension can be associated with cerebral damage, espe-
Baseline and Procedural Characteristics of thethe Presence o Absence of New Cerebral IscheTable 3 Baseline and Procedu al Ch ract rithe Presence or Absence of New Ce
Variables
Clinical characteristics
Age (yrs)
Male sex
Diabetes
Dyslipidemia
Hypertension
Current smokers
Chronic atrial fibrillation/flutter
Coronary artery disease
Prior stroke
Peripheral vascular disease
Carotid stenosis 50%
COPD
eGFR 60 ml/min
STS-PROM score (%)
Logistic EuroSCORE
Echocardiographic variables
Mean aortic gradient (mm Hg)
Aortic valve area (cm2)
LVEF (%)
LVEF 40%
Aortic annulus diameter (TEE, mm)
Aortic plaques 4 mm
Computed tomography
Aortic valve leaflet calcium volume (mm3)
Procedural variables
Valve diameter (mm)
23
26
Ratio aortic annulus/valve diameter
Rapid pacing runs
Procedure duration
Successful procedure
Procedural complications
Valve embolization
Valve malposition
Need for second valve
Severe hypotension needing hemodynamic support
Major access site complications
Life-threatening arrhythmias
Values are expressed as mean  SD, n (%), or median (interquartile r
Abbreviations as in Tables 1 and 2.ially in those patients with significant carotid disease (34). nhe TAVI with the Edwards valve involves at least 2 short
pisodes of extreme hypotension owing to the use of rapid
acing runs during balloon valvuloplasty and valve implan-
ation. However, no correlation was found between the
umber of rapid pacing runs and the presence and number
f new ischemic lesions in our study, and those patients with
arotid stenosis 50% did not exhibit a higher rate of new
esions. This strongly suggests that the occurrence of cere-
ral lesions was not related to the rapid pacing strategy. The
umber of patients with complications needing hemody-
Population According toesions F llowing TAVIof the Study Population According to
al Ischemic Lesions Following TAVI
New Cerebral Ischemic Lesions
p ValueYes (n  41) No (n  19)
83 8 82 6 0.79
24 (59) 6 (32) 0.09
11 (27) 4 (21) 0.75
31 (76) 13 (68) 0.55
32 (78) 13 (68) 0.52
1 (2) 0 1.00
10 (24) 4 (21) 1.00
33 (80) 11 (58) 0.11
7 (17) 2 (11) 0.71
14 (34) 5 (26) 0.77
3 (7) 3 (16) 0.37
9 (22) 5 (26) 0.74
35 (85) 18 (95) 0.41
8.1 5.2 6.9 2.9 0.27
19.5 14.2 17.6 9.5 0.59
44.8 19.3 38.6 11.2 0.12
0.63 0.19 0.65 0.12 0.55
54.5 12.1 56.3 15.9 0.65
8 (20) 2 (11) 0.48
22 2 21 2 0.66
10 (24) 7 (37) 0.36
0 (1,300–4,140) 1,830 (1,460–3,430) 0.88
18 (44) 10 (53) 0.78
21 (51) 9 (47)
0.83 0.21 0.87 0.04 0.23
5 2 5 2 0.29
82 (70–124) 96 (65–180) 0.27
40 (98) 19 (100) 1.00
0 0 —
1 (2) 0 1.00
2 (5) 0 1.00
1 (2) 1 (5) 0.54
2 (5) 3 (16) 0.31
2 (5) 0 1.00
or skewed variables.Studymic Ls s
rebr
2,34amic support was low (n  2), precluding any comprehen-
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erebral lesions.
ilent cerebral infarction and neurocognitive function.
t has been shown that silent cerebral infarction is frequently
ssociated with subtle deficits in physical and cognitive
unction that commonly go unnoticed, as well as with an
ncreased risk of subsequent stroke and dementia (35).
owever, previous studies regarding the clinical relevance of
erebral microemboli and silent cerebral ischemic lesions
uring cardiac procedures have reported mixed results.
aseline and Procedural Characteristics of the Study Population Acresence of None, Single, or Multiple New Cerebral Ischemic LesioTable 4 Bas line and Procedu al Charact ris ics of the Study PPresence of None, Single, or Multiple New Cerebral Isc
Variables
No Lesions
(n  19)
Baseline characteristics
Age (yrs) 82 6
Male sex 6 (32)
Diabetes 4 (21)
Dyslipidemia 13 (68)
Hypertension 13 (68)
Current smokers 0
Chronic atrial fibrillation/flutter 4 (21)
Coronary artery disease 11 (58)
Prior stroke 2 (11)
Peripheral vascular disease 5 (26)
Carotid stenosis 50% 3 (16)
COPD 5 (26)
eGFR 60 ml/min 18 (95)
STS-PROM score (%) 6.9 2.9
Logistic EuroSCORE 17.6 9.5
Echocardiographic variables
Mean aortic gradient (mm Hg) 39 11
Aortic valve area (cm2) 0.65 0.12
LVEF (%) 56 16
LVEF 40% 2 (11)
Aortic annulus diameter (TEE, mm) 21 2
Aortic plaques 4 mm 7 (37)
Computed tomography
Aortic valve leaflet calcium volume (mm3) 1,830 (1,460–3,
Procedural variables
Valve diameter (mm)
23 10 (53)
26 9 (47)
Ratio aortic annulus/valve diameter 0.87 0.04
Rapid pacing runs 5 2
Procedure duration 96 (65–180
Successful procedure 19 (100)
Procedural complications
Valve embolization 0
Valve malposition 0
Need for a second valve 0
Severe hypotension needing hemodynamic support 1 (5)
Major access site complications 3 (16)
Life-threatening arrhythmias 0
alues are expressed as mean  SD, n (%), or median (interquartile range) for skewed variables.
Abbreviations as in Tables 1 and 2.lthough some studies have shown no correlation between milent infarction and neurologic and cognitive functions
36–38), others have reported significant impairment in
eurocognitive functions in cases of cerebral embolism
ollowing a cardiac procedure (4,21,39). This might be due
n part to the method used for analysis of neurocognitive
unction. We used the MMSE, a quick screening tool of
lobal cognitive function, to evaluate cognitive function pre-
nd post-TAVI, and we did not find any association
etween the occurrence of new ischemic lesions and neuro-
ognitive function. We cannot exclude the possibility that a
ing to thellowing TAVIation According to the
ic Lesions Following TAVI
Single Lesions
(n  10)
Multiple Lesions
(n  31) p Value
84 7 82 8 0.86
6 (60) 18 (58) 0.17
2 (20) 9 (29) 0.78
8 (80) 23 (74) 0.86
7 (70) 25 (81) 0.66
0 1 (3) 0.87
1 (10) 9 (29) 0.55
8 (80) 25 (81) 0.21
2 (20) 5 (16) 0.80
7 (70) 7 (23) 0.03
2 (20) 1 (3) 0.13
3 (30) 6 (19) 0.71
8 (80) 27 (87) 0.42
9.7 7.7 7.5 4.1 0.28
18.6 10.9 19.8 15.2 0.84
49 14 44 21 0.31
0.56 0.21 0.65 0.19 0.31
54 15 55 11 0.89
2 (20) 6 (19) 0.72
21 2 22 2 0.45
4 (40) 6 (19) 0.28
3,030 (1,060–4,320) 2,320 (1,450–2,830) 0.90
5 (50) 13 (42) 0.77
4 (40) 17 (55)
0.77 0.29 0.85 0.17 0.30
6 3 5 2 0.54
82 (70–100) 82 (70–150) 0.25
9 (90) 31 (100) 0.17
0 0 —
0 1 (3) 1.00
0 2 (6) 0.67
1 (10) 0 0.23
0 2 (6) 0.45
0 2 (6) 0.67cordns Foopul
hem
430)
)ore extensive neurocognitive evaluation might have been
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nterestingly, Gerriets et al. (40) recently reported a mod-
rate but significant correlation between silent infarction
nd early cognitive function decrease following coronary
rtery bypass grafting, but this correlation disappeared at a
-month follow-up. Consistent with our results, Kahlert et
l. (8) did not find any measurable impairment in neuro-
ognitive function following TF-TAVI as evaluated by the
MSE, despite a high incidence (84%) of silent ischemic
vents. The reported incidence of clinically apparent stroke
ollowing TAVI has been between 2% and 4% in most
eries, also consistent with the results of the present study
16–20,41). Kahlert et al. (8) suggested that the incidence of
erebral embolism associated with TF-TAVI was higher
han that following surgical aortic valve replacement. How-
ver, no surgical studies to date have included such an
xtremely high risk group of patients as those treated by
AVI, and only the results of prospective studies such as the
ARTNER (Placement of Aortic Transcatheter Valve) trial
ill provide definite data comparing the rate of cerebrovas-
ular events following TAVI and surgical procedures.
tudy limitations. The comparison between the TF and
A groups was not performed in a randomized way.
owever, this was partially compensated for by the fact that
ery few differences in baseline characteristics were observed
etween the 2 groups, and none of the variables exhibiting
ifferences was found to be a predictor of cerebral embolism.
lso, the way patients were selected for TF or TA approach
eflects the clinical practice of the vast majority of clinical
AVI programs. We did not use transcranial Doppler, and
his precluded determining the type (solid vs. gaseous) and
iming of the cerebral microemboli during the TAVI
rocedure. Although this is the largest study evaluating the
ccurrence of cerebral embolism by DW-MRI following
AVI, the relatively small sample size might have limited
ur ability to detect independent predictors of cerebral
mbolism. Also, this was an exploratory study with a sample
ize determined on an empiric basis, and the results regard-
ng the absence of differences in cerebral embolism between
F and TA groups should be confirmed in a larger and
dequately powered sample size trial.
onclusions
his first multicenter study evaluating the incidence of
erebral embolism by DW-MRI after TA- and TF-TAVI
rocedures showed that new cerebral ischemic lesions oc-
urred in about two-thirds of the patients, regardless of the
pproach. The lack of differences between TA and TF
pproaches suggests that the mechanical stress of the aortic
alve during balloon valvuloplasty/valve implantation and
he occurrence of gaseous embolism might be the main
echanisms linking the TF- and TA-TAVI procedures to
erebral embolism. However, no predictive factors of cere-
ral embolism were found, reflecting the complexity of
valuating the mechanisms, which are probably multifacto-ial, of cerebral embolism in these procedures. These results
upport the need of further research to both improve the
rofile and reduce the size of TAVI catheters and evaluate
he efficacy of using protection systems for cerebral circula-
ion during TAVI.
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